MLKL-IN-6
Product Specifications
Target
Necroptosis, MLK
Related Pathways
Apoptosis, MAPK
Bioactivity
MLKL-IN-6 (compound P28) is a mixed lineage kinase inhibitor that specifically targets the Mixed Lineage Kinase domain-like (MLKL) protein. It effectively prevents MLKL phosphorylation and oligomerization, which are critical steps in cell necrosis. Additionally, MLKL-IN-6 restrains immune cell death, diminishes adhesion factor expression, exhibits low cytotoxicity, impedes hepatic stellate cell activation, decreases liver fibrosis marker levels, and exerts anti-fibrotic effects [1].
Smiles
OC1=CC(C#CCN2C(N=C(/C=C/C(OC)=O)N3C)=C3C(N(C)C2=O)=O)=CC=C1
Molecular Formula
C20H18N4O5
Molecular Weight
394.38
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
34740126 3x 1.0µg DNA
Olr853 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details 
E14306r 96 Tests
ELISA Kit For Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
Sign In for Pricing
View Details 